NRIX · Nurix Therapeutics, Inc.
$27.02
-0.77 (-2.77%)
At close · Aug 20
Market Cap
$2.88B
Shares
103.78M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2021-08 | 2024-10-31 | $300,000,000 | $204,600,000 as of 2025-11-30 | — | 10-K , filed 2026-01-28 |
Key facts
CIK
1549595
CUSIP
67080M103
13F (30d)
208 filings
201 filers
Visit website
Investor relations